Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-222880
Filing Date
2024-09-20
Accepted
2024-09-20 16:16:46
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d893946ds3.htm S-3 331921
2 EX-1.2 d893946dex12.htm EX-1.2 189209
3 EX-4.10 d893946dex410.htm EX-4.10 303003
4 EX-4.11 d893946dex411.htm EX-4.11 288589
5 EX-5.1 d893946dex51.htm EX-5.1 27125
6 EX-23.1 d893946dex231.htm EX-23.1 2180
7 EX-FILING FEES d893946dexfilingfees.htm EX-FILING FEES 65914
8 GRAPHIC g893946g04w47.jpg GRAPHIC 47018
9 GRAPHIC g893946g0918112848857.jpg GRAPHIC 1981
10 GRAPHIC g893946g31w31.jpg GRAPHIC 42104
  Complete submission text file 0001193125-24-222880.txt   1334902
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282260 | Film No.: 241313600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)